report
What lies ahead for New Zealand’s medical device market?
A shift in policy involves decreased funding for digital health, impacting the sector’s growth.
What lies ahead for New Zealand’s medical device market?
A shift in policy involves decreased funding for digital health, impacting the sector’s growth.
Maternity health insurance market to reach $269.3b by 2032
Its growth is fuelled by an increased adoption of life insurance services and strategic developments.
Saudi Arabia’s IoT in healthcare market to grow at 8.69% CAGR through 2029
An increasing demand for telemedicine is fuelling the sector.
Autoimmune disease testing market to be valued at $12.1b by 2033
One growth driver includes the rising prevalence of autoimmune diseases.
Global surgical microscopes market to reach $1.4b by 2030
Thanks to an increased demand in various medical fields.
Patient engagement technology market to rise by $37.4b through 2028
The sector is pivoting towards healthcare digitisation.
Sepsis drug development remains challenged amidst high trial failures
Currently, there are 14 drugs in late-stage development across eight major markets.
Global respiratory diagnostics market to be valued at $9.8b by 2030
Its growth is fuelled by an increase in diseases, such as asthma, COPD, and lung infections.
What factors fuel home blood testing devices market?
One key driver is the integration of artificial intelligence.
Femtech devices market to rise at 12.93% CAGR through 2028
Its expansion is attributed to the increasing rate of infertility and obesity-related cases in women.
Here’s what’s driving the APAC vascular stents market
One key factor is healthcare infrastructure advancements.
Global knee replacement market to grow at 3.16% CAGR until 2033
Advancements, such as nanotechnology and kinematic alignment, are driving its expansion.
Human immunoglobulin market to surge by $9.7b through 2028
One key driver is the rising demand for treatments in hospitals and homecare settings.
Global breathing circuits market to hit $2.16b by 2029
Its growth is attributed to an increase in surgical procedures and a rise in chronic diseases.
Pakistan's pharmaceutical sector faces hurdles despite economic zone plans
It is expected to grow at a slower rate compared to neighbouring South Asian markets.
Short-acting insulin market to cross $9b by 2030
Key drivers include technological advancements and evolving healthcare policies.
APAC to lead growth in the global cardiac tissue engineering market
The region’s expansion is attributed to a rise in cardiovascular disease,